Differences

This shows you the differences between two versions of the page.

--- en:start [2024/09/17 18:25]
Gianluca Frustagli
+++ en:start [2025/08/24 15:38] (current)
Gianluca Frustagli "Project GENEVAX": fixed link to logos.
@@ Line 12: / Line 12: @@
 The **[[https://www.iss.it|ISS]] - Core Facilities Technical-Scientific Service** is a centralized shared resource that provides access to instruments and technologies, as well as expert consultation, to scientific researchers.
-{{map> :esagoni-eng.png?380|Core facilities}}
+{{map> :esagoni-eng.png?300|Core facilities}}
 /* "Logo" ad esagoni con mappa dei link. Le coordinate sono scalate sull'immagine ridimensionata, riscalando l'immagine occorre (purtroppo) riscalare a mano anche le coordinate. */
-  * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 166,3,208,3,230,40,208,77,166,78,144,41]]
+  * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 124,100,175,100,201,144,176,189,125,189,99,145]]
-  * [[en:aree:ngs:start|Area Sequenziamento @ 308,84,351,84,372,121,351,158,308,158,287,122]]
+  * [[en:aree:ngs:start|Area Sequenziamento @ 209,53,260,52,286,97,261,141,209,141,185,97]]
-  * [[en:aree:fabiocell:start|Area FaBioCell @ 237,42,279,42,301,79,280,117,237,118,215,80]]
+  * [[en:aree:citometria:start|Area Citometria @ 210,149,261,149,286,193,261,238,210,238,185,193]]
-  * [[en:aree:citometria:start|Area Citometria @ 237,126,280,125,301,162,280,199,237,200,216,162]]
+  * [[en:aree:epr:start|Area EPR @ 125,197,176,197,201,241,176,286,125,285,100,242]]
-  * [[en:aree:epr:start|Area EPR @ 165,166,208,166,230,203,208,240,166,239,144,203]]
+  * [[en:aree:nmr:start|Area NMR @ 39,149,89,149,115,193,90,237,39,237,14,193]]
-  * [[en:aree:nmr:start|Area NMR @ 93,125,136,125,157,162,136,199,93,199,72,163]]
+  * [[en:aree:microscopia:start|Area Microscopia @ 98,48,124,3,174,3,200,47,174,92,124,91]]
-  * [[en:aree:microscopia:start|Area Microscopia @ 23,84,66,84,88,120,66,158,23,159,1,121]]
+  * [[en:aree:proteomica:start|Area Proteomica @ 39,51,90,51,116,94,91,139,39,139,14,95]]
-  * [[en:aree:proteomica:start|Area Proteomica @ 93,42,136,42,158,79,136,117,94,117,72,80]]
-  * [[en:aree:start|Aree @ 166,84,211,84,234,123,211,160,166,160,145,122]]
 {{<map}}
@@ Line 44: / Line 42: @@
 </WRAP>
-> Director: [[marco.crescenzi@iss.it|Marco Crescenzi]]
+> Director: [[franco.cardone@iss.it|Franco Cardone]]
-> ☎ **+39 06 4990 3163**
+> ☎ **+39 06 4990 3313**
+----
+\\
+[[https://www.corefacilitiesitalia.it|{{:nico-logo.png?150 |NICo Logo}}]] The ISS FAST Service adheres to the //**[[https://www.corefacilitiesitalia.it|Network Italiano Core Facilities]]**// (NICo) which was established in 2022 through a collaborative effort involving several [[https://www.corefacilitiesitalia.it/le-core-facilities/i-membri-di-nico|Italian Universities and Research Institutions]].
+NICo’s goal is to foster **positive synergies** among Core Facilities operating in the field of **Life Sciences** and to enhance their **visibility and accessibility**.
-/* > FIXME **To be revised by A.**\\ //(remove this paragraph once the translation is finished)// */
 \\
@@ Line 57: / Line 62: @@
 <ifintranet> /* BEGIN OF INTRANET VERSION "NEWS" */
+<WRAP centeralign>
+<wrap lo>October 23, 2024, Aula Marotta, 8:30 ~ 17:30</wrap>
+<wrap bigger>The role of Artificial Intelligence in diagnostic imaging</wrap>
+The objectives of the course are to update on the state of the art, the perspectives of AI in the different processes of acquisition and processing of images and its contribution to the diagnostic process and therapeutic follow-up. **[[en:eventi:2024:10:23:mri-ia|[read more...]]]**
+\\
+{{ :eventi:2024:10:23:ia-imaging-diag.jpeg?300 |AI/diagnostics subject fantasy banner}}
+</WRAP>
+----
+<WRAP group> /* Begin of row */
+<WRAP half column> /* Begin of column 1 */
+<wrap lo>September 9 ~ 13, 2024</wrap>
+<wrap bigger>NanoInnovation 2024</wrap>
+FAST - ISS's Core Facilities Service, will participate in the 2024 edition of [[https://www.nanoinnovation2024.eu|NanoInnovation]] with interventions included in the "BreakOut sessions". The title of the session is //"Biomedical applications of advanced spectroscopic techniques to study new contrast agents and cell metabolism in aging and oncology"// and will take place from 17:45 to 19:15 at the Faculty of Civil and Industrial Engineering, San Pietro in Vincoli Campus, Sapienza University of Rome, Via Eudossiana 18. **[[en:eventi:2024:09:09:nanoinnovation|[read more...]]]**
+\\
+{{ :eventi:2024:09:09:20240909-nanoinnovation.png?300 |NanoInnovation 2024 banner}}
+</WRAP> /* End of column 1 */
+<WRAP half column> /* Begin of column 2 */
 <wrap lo>2024/04/19</wrap>
@@ Line 66: / Line 101: @@
 {{ :aree:epr:altre_risorse:biacore:strumento.jpeg?250 }}
+</WRAP> /* End of column 2 */
+</WRAP> /* End of row */
 ----
+\\
 <WRAP group> /* Begin of row */
@@ Line 198: / Line 237: @@
 <wrap bigger>**GENEVAX Project**</wrap>
-{{ :aree:fabiocell:genevax-loghi.png?350 |}}
+{{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}}
-In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]]
+In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]]
@@ Line 383: / Line 422: @@
 </ifintranet> /* END OF INTRANET VERSION "NEWS" */
 <ifinternet> /* BEGIN OF INTERNET VERSION "NEWS" */
+<WRAP group> /* Begin of row */
+<WRAP half column> /* Begin of column 1 */
+<WRAP centeralign>
+<wrap lo>October 23, 2024, Aula Marotta, 8:30 ~ 17:30</wrap>
+<wrap bigger>The role of Artificial Intelligence in diagnostic imaging</wrap>
+The objectives of the course are to update on the state of the art, the perspectives of AI in the different processes of acquisition and processing of images and its contribution to the diagnostic process and therapeutic follow-up. **[[en:eventi:2024:10:23:mri-ia|[read more...]]]**
+\\
+{{ :eventi:2024:10:23:ia-imaging-diag.jpeg?300 |AI/diagnostics subject fantasy banner}}
+</WRAP>
+</WRAP> /* End of column 1 */
+<WRAP half column> /* Begin of column 2 */
+<wrap lo>September 9 ~ 13, 2024</wrap>
+<wrap bigger>NanoInnovation 2024</wrap>
+FAST - ISS's Core Facilities Service, will participate in the 2024 edition of [[https://www.nanoinnovation2024.eu|NanoInnovation]] with interventions included in the "BreakOut sessions". The title of the session is //"Biomedical applications of advanced spectroscopic techniques to study new contrast agents and cell metabolism in aging and oncology"// and will take place from 17:45 to 19:15 at the Faculty of Civil and Industrial Engineering, San Pietro in Vincoli Campus, Sapienza University of Rome, Via Eudossiana 18. **[[en:eventi:2024:09:09:nanoinnovation|[read more...]]]**
+\\
+{{ :eventi:2024:09:09:20240909-nanoinnovation.png?300 |NanoInnovation 2024 banner}}
+</WRAP> /* End of column 2 */
+</WRAP> /* End of row */
+----
+\\
 <WRAP group> /* Begin of row */
@@ Line 519: / Line 592: @@
 <wrap bigger>**GENEVAX Project**</wrap>
-{{ :aree:fabiocell:genevax-loghi.png?350 |}}
+{{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}}
-In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]]
+In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]]
@@ Line 630: / Line 703: @@
 </ifinternet> /* END OF INTERNET VERSION "NEWS" */